Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Sharmilan Thanendrarajan

Concepts (239)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
60
2025
2997
4.150
 Why?
Antibodies, Bispecific
6
2025
88
1.190
 Why?
Hematopoietic Stem Cell Transplantation
9
2024
578
1.100
 Why?
Leukemia, Plasma Cell
2
2020
32
0.860
 Why?
Immunotherapy, Adoptive
5
2024
163
0.710
 Why?
Bone Marrow
10
2022
363
0.690
 Why?
B-Cell Maturation Antigen
7
2025
99
0.680
 Why?
Neoplasms, Plasma Cell
3
2024
36
0.640
 Why?
Humans
69
2025
50509
0.590
 Why?
Plasma Cells
6
2023
221
0.580
 Why?
Chromosome Deletion
2
2023
134
0.580
 Why?
Transplantation, Autologous
10
2024
481
0.560
 Why?
Chromosomes, Human, Pair 17
1
2017
34
0.550
 Why?
Gene Expression Profiling
10
2023
1025
0.530
 Why?
Tumor Suppressor Protein p53
2
2017
213
0.520
 Why?
Clinical Trials as Topic
4
2022
486
0.510
 Why?
Gene Expression Regulation, Neoplastic
6
2021
833
0.510
 Why?
Neoplasm, Residual
6
2022
160
0.490
 Why?
Proteasome Inhibitors
1
2016
104
0.480
 Why?
Immunologic Factors
1
2016
111
0.480
 Why?
Monoclonal Gammopathy of Undetermined Significance
4
2024
112
0.480
 Why?
Aged
23
2025
9743
0.450
 Why?
Prognosis
15
2024
1978
0.440
 Why?
Immunotherapy
1
2016
235
0.440
 Why?
Stem Cell Transplantation
5
2024
179
0.430
 Why?
Translocation, Genetic
5
2021
240
0.430
 Why?
Mutation
7
2022
1281
0.420
 Why?
Antibodies, Monoclonal
2
2022
462
0.420
 Why?
Neoplasm Proteins
4
2020
320
0.400
 Why?
Neutropenia
2
2023
116
0.390
 Why?
Survival Analysis
8
2024
661
0.380
 Why?
Neoplasms
2
2012
1254
0.380
 Why?
Cytokine-Induced Killer Cells
1
2011
2
0.380
 Why?
Lymphocytes
1
2012
149
0.370
 Why?
Evolution, Molecular
2
2021
95
0.350
 Why?
Cancer Vaccines
1
2011
80
0.350
 Why?
Neoplasm Recurrence, Local
7
2024
629
0.350
 Why?
Positron-Emission Tomography
4
2022
293
0.340
 Why?
Diffusion Magnetic Resonance Imaging
3
2019
125
0.330
 Why?
Cytokines
1
2012
606
0.310
 Why?
Tumor Microenvironment
3
2024
222
0.300
 Why?
Female
27
2025
27086
0.290
 Why?
Middle Aged
21
2025
12614
0.290
 Why?
Aged, 80 and over
9
2025
3228
0.290
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2024
1000
0.290
 Why?
Hematologic Neoplasms
2
2022
99
0.290
 Why?
Combined Modality Therapy
4
2024
641
0.270
 Why?
Atrial Fibrillation
2
2022
188
0.270
 Why?
Male
25
2025
25910
0.250
 Why?
Adult
17
2025
13583
0.240
 Why?
Fluorodeoxyglucose F18
4
2021
189
0.230
 Why?
Proto-Oncogene Proteins B-raf
3
2020
80
0.230
 Why?
Immunoglobulins, Intravenous
1
2025
65
0.230
 Why?
Polycomb Repressive Complex 2
2
2021
46
0.230
 Why?
Neoplasms, Second Primary
1
2024
74
0.220
 Why?
Treatment Outcome
8
2024
5285
0.220
 Why?
Chromosomes, Human, Pair 1
2
2023
92
0.210
 Why?
Disease Progression
6
2021
829
0.200
 Why?
Risk Factors
9
2024
3724
0.200
 Why?
Paraproteinemias
1
2022
72
0.200
 Why?
Immunoconjugates
1
2022
37
0.190
 Why?
Osteolysis
1
2022
74
0.190
 Why?
Drug Approval
1
2022
47
0.190
 Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.190
 Why?
Lymphoma, B-Cell
1
2022
49
0.190
 Why?
Recurrence
6
2024
659
0.190
 Why?
Epigenomics
1
2021
68
0.190
 Why?
Patient Participation
1
2022
70
0.190
 Why?
T-Lymphocytes
4
2024
325
0.180
 Why?
Genes, Tumor Suppressor
2
2021
73
0.170
 Why?
Cell Cycle
1
2021
226
0.170
 Why?
Practice Guidelines as Topic
1
2023
468
0.170
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
 Why?
Bone Resorption
1
2022
302
0.170
 Why?
Bone Diseases
1
2021
96
0.170
 Why?
Retrospective Studies
8
2025
6263
0.170
 Why?
Gene Regulatory Networks
1
2020
106
0.160
 Why?
Chromosomal Instability
1
2019
16
0.160
 Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
 Why?
Disease-Free Survival
5
2019
444
0.160
 Why?
Antigens, CD
1
2020
222
0.160
 Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
 Why?
Healthcare Disparities
1
2022
281
0.160
 Why?
Spleen
1
2019
169
0.150
 Why?
Spinal Fractures
1
2018
38
0.150
 Why?
Phosphotransferases
1
2018
16
0.150
 Why?
Antineoplastic Agents
2
2024
1172
0.150
 Why?
Bacteremia
1
2019
88
0.150
 Why?
Brain Neoplasms
2
2011
291
0.150
 Why?
Adipocytes
1
2018
126
0.140
 Why?
Gene Rearrangement
1
2018
65
0.140
 Why?
Hexokinase
1
2017
17
0.140
 Why?
Retinoblastoma Binding Proteins
1
2017
11
0.140
 Why?
Calcification, Physiologic
1
2017
40
0.140
 Why?
Epigenesis, Genetic
1
2020
372
0.140
 Why?
Pelvis
1
2017
66
0.130
 Why?
Cell Proliferation
4
2023
985
0.130
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
90
0.130
 Why?
Survival Rate
4
2020
909
0.130
 Why?
Immunoglobulin Light Chains
1
2017
84
0.130
 Why?
Ubiquitin-Protein Ligases
1
2017
95
0.130
 Why?
Clonal Evolution
1
2016
56
0.130
 Why?
Flow Cytometry
1
2018
474
0.130
 Why?
Gene Expression Regulation, Enzymologic
1
2017
179
0.130
 Why?
Gene Expression
1
2018
610
0.120
 Why?
Animals
4
2024
13124
0.120
 Why?
Cystatin M
2
2024
19
0.110
 Why?
Cross-Sectional Studies
3
2023
1609
0.100
 Why?
Cardiovascular Diseases
1
2017
461
0.100
 Why?
Follow-Up Studies
3
2024
2241
0.090
 Why?
Lymphoma, Non-Hodgkin
1
2011
55
0.090
 Why?
Astrocytoma
1
2011
21
0.090
 Why?
Disease Models, Animal
1
2016
1436
0.090
 Why?
Mutation Rate
2
2021
35
0.090
 Why?
In Situ Hybridization, Fluorescence
2
2023
231
0.090
 Why?
Glioma
1
2011
77
0.090
 Why?
Alleles
2
2021
256
0.080
 Why?
Genomics
2
2023
279
0.080
 Why?
Remission Induction
2
2021
208
0.080
 Why?
Tumor Burden
2
2020
130
0.080
 Why?
Proto-Oncogene Proteins p21(ras)
2
2021
67
0.080
 Why?
Histones
2
2021
297
0.080
 Why?
Vaccination
1
2011
280
0.080
 Why?
Transcription Factors
2
2023
565
0.080
 Why?
DNA Copy Number Variations
2
2021
109
0.080
 Why?
Radiopharmaceuticals
2
2021
204
0.080
 Why?
Models, Biological
1
2011
716
0.070
 Why?
Cell Differentiation
2
2022
640
0.070
 Why?
Transcriptome
2
2020
314
0.070
 Why?
Kaplan-Meier Estimate
2
2019
464
0.070
 Why?
Imaging, Three-Dimensional
2
2017
151
0.060
 Why?
Biopsy
2
2018
588
0.060
 Why?
Arkansas
2
2021
1984
0.060
 Why?
Killer Cells, Natural
1
2024
106
0.060
 Why?
Ferritins
1
2024
30
0.060
 Why?
Demography
1
2024
94
0.050
 Why?
Myeloid Progenitor Cells
1
2023
17
0.050
 Why?
X-Ray Microtomography
1
2024
79
0.050
 Why?
CD8-Positive T-Lymphocytes
1
2024
125
0.050
 Why?
Receptors, G-Protein-Coupled
1
2024
49
0.050
 Why?
Antibodies
1
2024
153
0.050
 Why?
Mice
2
2024
5687
0.050
 Why?
Signal Transduction
2
2021
1624
0.050
 Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
 Why?
Patients
1
2022
48
0.050
 Why?
Geography
1
2022
60
0.050
 Why?
Myeloid Differentiation Factor 88
1
2022
32
0.050
 Why?
Patient Selection
1
2023
259
0.050
 Why?
United States Food and Drug Administration
1
2022
90
0.050
 Why?
Oncogenes
1
2021
57
0.050
 Why?
Chromosome Aberrations
1
2023
280
0.050
 Why?
Dexamethasone
1
2024
432
0.050
 Why?
Phylogeny
1
2022
236
0.050
 Why?
Bone Marrow Transplantation
1
2022
136
0.050
 Why?
Syndecan-1
1
2021
75
0.050
 Why?
SOXC Transcription Factors
1
2021
13
0.050
 Why?
RANK Ligand
1
2022
187
0.050
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
81
0.050
 Why?
Transcriptional Activation
1
2021
119
0.050
 Why?
Chromatin
1
2021
137
0.050
 Why?
Clone Cells
1
2021
70
0.050
 Why?
Antibodies, Monoclonal, Humanized
1
2022
225
0.040
 Why?
Pyrimidines
1
2022
191
0.040
 Why?
Cyclin D2
1
2020
20
0.040
 Why?
Aneuploidy
1
2020
18
0.040
 Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
 Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
 Why?
Chromosomes, Human, Pair 11
1
2020
49
0.040
 Why?
Histone Code
1
2020
30
0.040
 Why?
Gene Expression Regulation, Leukemic
1
2020
29
0.040
 Why?
Cyclin D1
1
2020
52
0.040
 Why?
ras Proteins
1
2020
64
0.040
 Why?
Genome, Human
1
2021
109
0.040
 Why?
Protein Kinase Inhibitors
1
2022
204
0.040
 Why?
Chromosomes, Human, Pair 14
1
2020
66
0.040
 Why?
DNA, Neoplasm
1
2020
143
0.040
 Why?
Health Status Disparities
1
2022
202
0.040
 Why?
Genetic Variation
1
2020
207
0.040
 Why?
DNA Mutational Analysis
1
2020
175
0.040
 Why?
Cell Line, Tumor
1
2023
1398
0.040
 Why?
High-Throughput Nucleotide Sequencing
1
2020
170
0.040
 Why?
Osteoclasts
1
2022
427
0.040
 Why?
Multivariate Analysis
1
2021
583
0.040
 Why?
Gram-Positive Bacterial Infections
1
2019
27
0.040
 Why?
Computational Biology
1
2020
215
0.040
 Why?
Pseudomonas Infections
1
2019
48
0.040
 Why?
Syndrome
1
2019
240
0.040
 Why?
Fractures, Compression
1
2018
17
0.040
 Why?
DNA-Binding Proteins
1
2021
418
0.040
 Why?
Promoter Regions, Genetic
1
2020
465
0.040
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
46
0.040
 Why?
Oncogene Proteins, Fusion
1
2018
57
0.040
 Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
8
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
27
0.040
 Why?
Protein-Tyrosine Kinases
1
2018
88
0.040
 Why?
Kidney Function Tests
1
2017
51
0.040
 Why?
STAT3 Transcription Factor
1
2017
77
0.040
 Why?
Retinoblastoma Protein
1
2017
19
0.030
 Why?
False Positive Reactions
1
2017
59
0.030
 Why?
Fibroblast Growth Factors
1
2017
45
0.030
 Why?
Bone and Bones
1
2021
478
0.030
 Why?
Glomerular Filtration Rate
1
2017
119
0.030
 Why?
Mitogen-Activated Protein Kinases
1
2017
155
0.030
 Why?
Amino Acid Sequence
1
2018
574
0.030
 Why?
Alkaline Phosphatase
1
2017
93
0.030
 Why?
Sequence Analysis, DNA
1
2017
226
0.030
 Why?
Genes, ras
1
2016
43
0.030
 Why?
Genes, p53
1
2016
49
0.030
 Why?
NF-kappa B
1
2018
315
0.030
 Why?
Glycolysis
1
2016
69
0.030
 Why?
DNA Methylation
1
2020
550
0.030
 Why?
Models, Genetic
1
2016
172
0.030
 Why?
Genomic Instability
1
2016
90
0.030
 Why?
Staphylococcal Infections
1
2019
265
0.030
 Why?
Image Interpretation, Computer-Assisted
1
2016
106
0.030
 Why?
Logistic Models
1
2018
900
0.030
 Why?
Phosphatidylinositol 3-Kinases
1
2016
140
0.030
 Why?
Melphalan
1
2016
178
0.030
 Why?
Heart
1
2017
341
0.030
 Why?
Kidney Diseases
1
2017
213
0.030
 Why?
Algorithms
1
2018
628
0.030
 Why?
Echocardiography
1
2017
399
0.030
 Why?
Time Factors
1
2021
2934
0.030
 Why?
Myocardium
1
2017
445
0.030
 Why?
Disease Management
1
2015
178
0.030
 Why?
Thalidomide
1
2016
378
0.030
 Why?
Longitudinal Studies
1
2016
734
0.030
 Why?
Risk Assessment
1
2018
1270
0.030
 Why?
Dose-Response Relationship, Drug
1
2016
1372
0.030
 Why?
Ifosfamide
1
2011
11
0.020
 Why?
Dacarbazine
1
2011
10
0.020
 Why?
Carboplatin
1
2011
54
0.020
 Why?
Tomography, X-Ray Computed
1
2017
1169
0.020
 Why?
Etoposide
1
2011
77
0.020
 Why?
United States
1
2022
4958
0.020
 Why?
Treatment Failure
1
2011
118
0.020
 Why?
Fatal Outcome
1
2011
197
0.020
 Why?
Drug Administration Schedule
1
2011
370
0.020
 Why?
Magnetic Resonance Imaging
1
2017
1555
0.020
 Why?
Thanendrarajan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (239) concept(s)
_
Co-Authors Expand Description
See all (48) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department